
Sun Pharma Q4 net profit at ₹1,984 crore
The Hindu
Sun Pharmaceutical Industries Ltd. reported that its fourth quarter consolidated net profit grew to ₹1,984.5 crore compared with net loss of ₹2,277.3 crore in the same period last year, due to improved performance.
Sun Pharmaceutical Industries Ltd. reported that its fourth quarter consolidated net profit grew to ₹1,984.5 crore compared with net loss of ₹2,277.3 crore in the same period last year, due to improved performance.
Gross sales at ₹10,725.6 crore grew 14.3% Year on Year (YoY), the company said in a press release.
India formulation sales at ₹3,364.1 crore was up 8.7% YoY and US formulation sales at $430 million was up 10.5% compared with Q4 last year, it said.
Emerging Markets formulation sales at $221 million, was up 7.5% while Rest of World formulation sales at $191 million was up 7.4% YoY, the company added.
For the financial year ended March 31, 2023 the company reported a net profit of ₹8,473.6 crore compared with ₹3,272.7 crore last year.
Gross sales at ₹43,278.9 crore grew 12.6% over the same period last year.
The Board has proposed a final dividend of ₹4 per share for the year FY23. This is in addition to the interim dividend of ₹7.5 per share paid in FY23, taking the total dividend for FY23 to ₹11.5 per share compared to ₹10 per share for FY22.

GCCs keep India’s tech job market alive, even as IT services industry embarks on a hiring moratorium
Global Capability Centres, offshore subsidiaries set up by multinational corporations, mostly known by an acronym GCCs, are now the primary engine sustaining India’s tech job market, contrasting sharply with the hiring slowdown witnessed by large firms in the country.

Mobile phones are increasingly migrating to smaller chips that are more energy efficient and powerful supported by specialised Neural Processing Units (NPUs) to accelerate AI workloads directly on devices, said Anku Jain, India Managing Director for MediaTek, a Taiwanese fabless semiconductor firm that claims a 47% market share India’s smartphone chipset market.

In one more instance of a wholly owned subsidiary of a Chinese multinational company in India getting ‘Indianised’, Bharti Enterprises, a diversified business conglomerate with interests in telecom, real estate, financial services and food processing among others, and the local arm of private equity major Warburg Pincus have announced to collectively own a 49% stake in Haier India, a subsidiary of the Haier Group which is headquartered in Qingdao, Shandong, China.










